<DOC>
	<DOCNO>NCT00236080</DOCNO>
	<brief_summary>The purpose study compare overnight efficacy plasma concentration-time profile armodafinil PROVIGIL , multiple dos , patient excessive sleepiness associate chronic Shift Work Sleep Disorder ( SWSD ) .</brief_summary>
	<brief_title>Study Efficacy Multiple-Dose Plasma Concentration-Time Profiles Armodafinil PROVIGIL</brief_title>
	<detailed_description>A Randomized , Double-Blind , Placebo-Controlled , Parallel-Group Study Efficacy Multiple-Dose Plasma Concentration-Time Profiles Armodafinil PROVIGIL Patients Chronic Shift Work Sleep Disorder</detailed_description>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Sleep Disorders , Circadian Rhythm</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>Patients include study follow criterion meet : The patient speak write English . The patient man woman ethnic origin age 18 65 year . The patient good health determine medical psychiatric history , medical examination , serum chemistry , hematology . The patient diagnosis SWSD accord International Classification Sleep Disorders ( ICSD ) criterion , must excessive sleepiness night shift least 3 month . The patient must plan work least 3 5 night ( per week ) , least 3 night consecutive . The patient must work night shift include least 6 hour 2200 0800 ( +30 minute ) long 12 hour ( +30 minute ) duration . The patient mean sleep latency 6 minute less determined MSLT ( average nap 0100 , 0300 , 0500 , 0700 ) . The patient Clinical Global Impression Severity Illness ( CGIS ) rating 4 pertains sleepiness night shift include commute work . Women childbearing potential ( surgically sterile 2 year postmenopausal ) must use medically accept method contraception must agree continue use method duration study 30 day participation study . Acceptable method contraception include abstinence , barrier method spermicide , steroidal contraceptive ( oral , transdermal , implanted inject ) conjunction barrier method , intrauterine device ( IUD ) . The patient willing comply study restriction remain clinic overnight require . The patient may prescribe PROVIGIL stimulant therapy sleep disorder ; however , must undergo washout period least 7 day prior screen assessment do second screen visit . Patients exclude participate study 1 follow criterion meet : The patient clinically significant medical psychiatric condition ( treat untreated ) . The patient probable diagnosis current sleep disorder SWSD . The patient consumes caffeine include coffee , tea , and/or caffeinecontaining beverage foods average 600 mg caffeine/day within 2 week start study drug administration . The patient medically unexplainable positive urine drug screen ( UDS ) result screen visit . The patient clinically significant deviation normal clinical laboratory result , vital sign , physical examination . The patient receive investigational drug within 30 day 5 halflives ( whichever longer ) study drug administration , case new chemical entity , 3 month 5 halflives ( whichever longer ) study drug adminstration . The patient use prescription drug disallow protocol clinical significant use overthecounter ( OTC ) drug within 7 day second screening/baseline visit . The patient disorder ( include gastrointestinal surgery ) may interfere drug absorption , distribution , metabolism , excretion . The patient know suspected hypersensitivity stimulant and/or modafinil ingredient present study drug . The patient history ( within past 5 year ) alcohol , narcotic , drug abuse define Diagnostic Statistical Manual Mental Disorders American Psychiatric Association , Fourth Edition , Text Revision ( DSMIVTR ) . The patient pregnant lactate woman . The patient donate , within 56 day prior study drug administration , blood plasma excess 450 mL .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>